Werkzaam bij het Ommelander Ziekenhuis sinds

2016

Specialisaties

Algemene dermatologie, dermato-oncologie, dermatochirurgie, acneïforme dermatosen

Opleidingen en werkervaring

2016 — heden Dermatoloog, bij Ommelander Ziekenhuis
2015 — 2016 Dermatoloog, bij Universitair Medisch Centrum Groningen (UMCG)
2009 — 2015 AIOS dermatologie, bij UMCG
2009 — 2012 Promotie UMCG (proefschrift 'Junctional epidermolysis bullosa')
2008 — 2009 ANIOS, bij Dermatologie ziekenhuis Viecuri Venlo
2002 — 2008 Geneeskunde, bij Radboud universiteit Nijmegen

Wetenschappelijke publicaties

 
• Rondags A, Yuen WY, Jonkman MF, Horváth B. Fullerene C60 with cytoprotective and cytotoxic potential: prospects as a novel treatment agent in Dermatology? Experimental Dermatology 2016 Epub ahead of print
• Yuen WY, Di Zenzo G, Jonkman MF, Pas HH. New versatile monoclonal antibodies against type XVII collagen endodomain for diagnosis and subtyping COL17A1-associated junctional epidermolysis bullosa. Journal of the European Academy of Dermatology and Venereology 2016 Aug;30(8):1426-7
• Snauwaert JJ, Yuen WY, Jonkman MF, Moons P, Naulaers G, Morren MA. Burden of itch in epidermolysis bullosa. British Journal of Dermatology 2014;171(1):73-8
• Yuen WY, Frew JW, Veerman K, van den Heuvel ER, Murrell DF, Jonkman MF. Health-related quality of life in epidermolysis bullosa: validation of the Dutch QOLEB questionnaire and assessment in the Dutch population. Acta Dermato-Venereologica 2014;94(4):442-7
• Yuen WY, Sinke RJ, Jonkman MF. ITGB4-associated junctional epidermolysis bullosa, type non-Herlitz: report of two new cases carrying two novel ITGB4 mutations. British Journal of Dermatology 2013 ;168(2):432-4
• Yuen WY, Huizinga J, Jonkman MF. Punch grafting of chronic ulcers in patients with laminin-332 deficient, non-Herlitz junctional epidermolysis bullosa. Journal of the American Academy of Dermatology 2013 Jan;68(1):93-7
• Yuen WY, Duipmans JC, Molenbuur B, Herpertz I, Mandema JM, Jonkman MF. Long-term follow-up of patients with Herlitz type junctional epidermolysis bullosa. British Journal of Dermatology 2012;167(2):374-82
• Yuen WY, Duipmans JC, Jonkman MF. The needs of parents with children suffering from lethal epidermolysis bullosa. British Journal of Dermatology 2012 ;167(3):613-8
• Yuen WY, Pasmooij AMG, Stellingsma C, Jonkman MF. Enamel defects in carriers of a novel LAMA3 mutation underlying epidermolysis bullosa. Acta Dermato-Venereologica 2012;92(6):695-6
• Yuen WY, Jonkman MF. Reply to: “Squamous cell carcinoma and junctional epidermolysis bullosa”. Journal of the American Academy of Dermatology 2012; 66(5):857-8
• Yuen WY, Lemmink HH, van Dijk-Bos K, Sinke RJ, Jonkman MF. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence, and population carrier frequency in the Netherlands. British Journal of Dermatology 2011; 165(6):1314-22
• Yuen WY, Jonkman MF. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of seven cases and a review of the literature. Journal of the American Academy of Dermatology 2011; 65(4):780-9
• Yuen WY, Pas HH, Sinke RJ, Jonkman MF. Junctional epidermolysis bullosa of late onset explained by mutations in COL17A1. British Journal of Dermatology 2011; 164(6):1280-4
• Yuen WY (2011) The ‘précis’ of Darier. In: Everdingen, J., Menke, H. Canon of the Dermatology (pp.24-25). Haarlem: DCHG
• Yuen WY, Schuttelaar MLA., Barkema LW, Coenraads PJC. Bullous allergic contact dermatitis to lidocaine. Contact Dermatitis 2008 Nov;61(5):300-301
• Yuen W, van der Valk P, van der Vleuten C. The Difficult Ulcus Cruris: a retrospective study to the benefits of a clinical admission. Nederlands tijdschrift voor Dermatologie en Venerologie 2009 Aug;19(7):357-360